Retour

Explorez tous les épisodes du podcast The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest

Plongez dans la liste complète des épisodes de The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest. Chaque épisode est catalogué accompagné de descriptions détaillées, ce qui facilite la recherche et l'exploration de sujets spécifiques. Suivez tous les épisodes de votre podcast préféré et ne manquez aucun contenu pertinent.

Rows per page:

1–35 of 35

TitreDateDurée
1: Introducing the Tell-Tale Heart Podcast25 Mar 202500:04:21
3: Updates to Acute Coronary Syndrome Guidelines 08 Apr 202500:36:52
This week, expert Steven Dunn, PharmD, FAHA, FCCP, BCCP, discusses the 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Read the guidelines here: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001309 
2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session01 Apr 202501:20:05

This episode discussed multiple studies. See the list below for links to articles and relevant content: 

REVERSE-IT trial data:  FAIR-HF2 trial data:  STRIDE trial data:  ADVANCE-HTN trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/15/49/advance-htn

FRESH-UP trial: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2025/03/27/17/26/fresh-up

FINEARTS-HF trial: https://www.acc.org/Latest-in-Cardiology/Journal-Scans/2025/03/05/17/27/FINEARTS-HF-Analysis

4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus22 Apr 202500:39:02
Host Craig Beavers spoke with Arthur Allen, PharmD, for the latest updates from the RIVAWAR trial of rivaroxaban and a discussion of the newest Acute Coronary Syndrome Guidelines for left ventricular thrombus.

For more information:
5: Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management06 May 202500:39:10
Host Craig Beavers spoke with Lavinia Salama, PharmD, clinical assistant professor at the University of Wyoming, about cardio-kidney-metabolic syndrome and how pharmacists can be at the forefront of serving patients. Salama also discusses her work in rural communities and why pharmacists are so crucial for those patients.

Show Notes:
34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective24 Jun 202600:33:41
In this episode of The Tell-Tale Heart, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, welcomes back Lavinia Salama, PharmD, BCACP, BCGP, BC-ADM, CDCES, for an in-depth look at the new cardiovascular-kidney-metabolic (CKM) guidelines and how they translate into everyday practice. Salama says she's encouraged that CKM recommendations have evolved from a conceptual framework into a formal, multisociety guideline, with new emphasis on albuminuria, the PREVENT risk equation, and routine screening for obstructive sleep apnea, MASLD/MASH, and social determinants of health.
33: Craig Beavers, PharmD Breaks Down the 2026 CKM Guidelines — And Why They Matter10 Jun 202600:12:09
In this solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, delivers an immediate reaction to the newly released 2026 AHA/ACC/ADA/ASN guidelines for cardiovascular kidney metabolic (CKM) syndrome. Beavers calls the document a landmark framework that formally unites obesity, diabetes, chronic kidney disease, heart failure, and atherosclerotic cardiovascular disease into a single disease continuum — a shift he argues changes everything about how clinicians should approach prevention. 
25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care03 Feb 202600:33:14

Learn more about the POLY-HF trial here.

You can reach the guests on this episode here:

Nick Miller, PharmD, on LinkedIn

  • Nick Miller can be reached at nick@rxcompound.com
Ambarish Pandey, MD, on LinkedIn
24: Hypertrophic Cardiomyopathy: What Pharmacists Need to Know in 202620 Jan 202600:51:11

Join us for a deep dive into hypertrophic cardiomyopathy (HCM) with Andrew Williford, PharmD, an assistant professor and cardiology specialist at UC San Diego Health. In this episode, we break down the genetics, diagnosis, and clinical impact of HCM, explore how management strategies have evolved, and discuss the emerging role of cardiac myosin inhibitors in treating obstructive disease. Dr. Williford also shares insights from his telehealth GDMT titration clinic and offers practical guidance for pharmacists encountering HCM across care settings.

Show notes:

23: Happy New Year from The Tell-Tale Heart!06 Jan 202600:01:44

Happy New Year from The Tell-Tale Heart! We'll be back in 2 weeks with a new episode. In the meantime, check out the recent episode of Drugstore Dialogue with host Barry Newman, who spoke with Craig Beavers about cardiology pharmacy.

Listen here: https://www.spreaker.com/episode/dr-craig-beavers--67706988 

22: From Diagnosis to Transplant: A Heart Failure Patient’s Journey and the Pharmacists’ Impact Along the Way16 Dec 202500:53:43
In this episode, host Craig Beavers sits down with Marc Baines, cofounder and executive director of the HeartLife Foundation, to explore heart failure care through the lens of lived experience. Diagnosed with heart failure at just 23 years old, Baines shares his path from sudden diagnosis to heart transplant and the critical role pharmacists played as consistent, trusted members of his care team. From medication education and adherence to quality-of-life conversations and continuity across care settings, this discussion offers pharmacists practical insights into how their everyday interactions can profoundly shape patient outcomes, empowerment, and long-term cardiovascular care.
Have feedback on this episode or ideas for future topics you’d like us to cover? Let us know—we’d love to hear what matters most to your practice. Email AAntrim@pharmacytimes.com with your feedback and ideas!
Show notes:
·       Learn more about the HeartLife Foundation
21: Breaking Down Celebrate and POLY-HF: Two Paths to Better Cardiac Care02 Dec 202500:12:54
In this solo episode, Craig Beavers breaks down new data from the CELEBRATE STEMI trial and the POLY-HF polypill study. He highlights what these findings could mean for real-world practice, from early antiplatelet strategies to improving adherence and outcomes in heart failure.

Show Notes:
20: Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition18 Nov 202501:02:48
This week, host Craig Beavers spoke with Joe Sassine, PharmD, BCPS, BCACP, CLS, about several key trials presented at the American Heart Association 2025 Scientific Sessions.

Show notes:
19: Jazzed Up for American Heart Association 2025 in New Orleans04 Nov 202500:52:35
Studies discussed in today's episode:

18: The Adipokine Hypothesis and Inflammation: Explaining Pathogenesis and Guiding Treatment21 Oct 202500:30:01
The articles discussed in this episode:
17: New Frontiers in Hypertension Care: Insights from the KARDIA-3 and Bax Hypertension Trials07 Oct 202500:54:20
Shelby Tungate Lopez, PharmD, CPP, BCACP, MPA is a clinical pharmacist practitioner at the UNC Eshelman School of Pharmacy. He can be reached on Linkedin @ShelbyTungateLopez, and more information can be found about his interests and work at his faculty page.

16: Deconstructing Meta-Analyses From ESC 202523 Sep 202500:54:46
Pooled Analysis From VICTOR and VICTORIA Trials
β Blocker After Myocardial Infarction Meta Analysis
32: What's Making Headlines in Cardiovascular Care: A Pharmacist's Breakdown of the Latest Breakthroughs27 May 202600:08:55
In this mini news episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, highlights three major developments in cardiovascular and cardiometabolic medicine that pharmacists should have on their radar.
15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials09 Sep 202500:42:16
Host Craig Beavers sits down with Lorenz van der Linden, a Belgian pharmacist, to dive deep into 2 groundbreaking trials from the European Society of Cardiology (ESC) 2025 Congress. They explore the ALONE-AF trial, which examined anticoagulation strategies for patients with atrial fibrillation after catheter ablation, and the AQUATIC trial, which investigated the role of aspirin in patients on oral anticoagulation. With their expert analysis, Craig and Lawrence break down the clinical implications, methodological nuances, and potential practice-changing insights from these important cardiovascular studies.

Show notes:
14: Sifting Through Discordant Data From ESC 202505 Sep 202500:50:17
Following the European Society of Cardiology Congress 2025, experts sat down again with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, to discuss key findings from the meeting. Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, reviewed new data from the meeting and parsed through their lingering questions.

Show Notes:
13: From Guidelines to Action: Pharmacy’s Role in Hypertension Management26 Aug 202500:40:40
In this episode, host Craig Beavers sits down with Gary Owen, clinical pharmacist and manager of Population Health Pharmacy Services at Vanderbilt University Medical Center, to discuss the newly updated ACC/AHA hypertension guidelines and what they mean for pharmacists. Gary shares how his team supports primary care providers across the state through collaborative practice agreements, innovative telephonic care models, and value-based care initiatives. The conversation explores how pharmacists can play a pivotal role in optimizing medication management, improving patient access, and driving better outcomes in chronic disease care.

Read the guidelines here.
12: A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 202512 Aug 202500:27:04
This week, host Craig Beavers tackles the upcoming European Society of Cardiology (ESC) Congress 2025, taking place August 29 through September 1, 2025.  Key data to keep an eye on will include the following: 
  • The VICTORION-Difference study of inclisiran in hyperlipidemia
  • The Essence study of olezarsen in hypertriglyceridemia
  • Multiple studies on early discontinuation of aspirin after percutaneous coronary intervention in high-risk acute coronary syndromes
  • The DAPT-SHOCK-AMI trial of cangrelor in patients with cardiogenic shock related to acute myocardial infarction
  • The ALONE-AF trial about stopping anticoagulation after successful atrial fibrillation ablation
  • The ODYSSEY-HCM and MAPLE-HCM studies on mavacamten and aficamten in hypertrophic cardiomyopathy
Stay tuned on upcoming episodes for deeper dives into these data and other key takeaways from ESC!
11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 202529 Jul 202501:06:24
In this episode, Kaitlin Hile, PharmD, BCCP; Robert Page, PharmD, MSPH, BCPS (AQ-cards), BCGP, FAHA, FHFSA, FCCP, FASHP; and Robert DiDomenico, PharmD, FCCP, FHFSA, FACC, sat down with host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS (AQ-cards), CACP, for an exciting discussion of several Hot Line trials at the upcoming European Society of Cardiology Congress 2025.

Learn more about the ESC Congress 2025 Hot Line sessions here.
10: COBRRA Trial Results Raise Questions About VTE Management15 Jul 202500:31:46
This week, host Craig Beavers sat down with Tara Lech, PharmD, CACP, director of anticoagulation services at Beth Israel Lahey Health, to discuss recent findings from the COBBRA trial, which compared bleeding risk with rivaroxaban versus apixaban.
9: An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial01 Jul 202500:44:50
Host Craig Beavers sits down with Kazuhiko Kido, PharmD, a clinical associate professor at the West Virginia University School of Pharmacy, to discuss intravenous iron and its use in patients with heart failure, as well as findings from the FAIR-HF2 clinical trial.

Show notes:
8: Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care17 Jun 202500:41:07
Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee. Finks reviews exactly what concierge medicine is, as well as its role in cardio-kidney-metabolic health and her own research on compounded GLP-1 and GIP agonists in a pharmacist-managed cardiometabolic clinic.

Show Notes:
7: New Programs Aim to Improve Implementation of Cardiovascular Interventions02 Jun 202500:53:04
Ralph Riello, PharmD, BCPS, a board-certified clinical pharmacy specialist at the Yale University School of Medicine, discusses challenges in implementation for novel cardiovascular treatments and interventions. In his work, Riello has researched the use of proactive messaging to providers to better implement new treatments, finding success with this approach.
6: Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial20 May 202500:40:36
Host Craig Beavers speaks with Orly Vardeny, PharmD, MS, a professor of medicine at the University of Minnesota. Vardeny discusses her own career path, the importance of mentors, and pharmacist involvement in clinical research, such as her work with the FINEARTS-HF study of finerenone in heart failure.

Show Notes: 
31: From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management12 May 202600:53:56
In this episode of The Tell-Tale Heart, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, speaks with Rhonda Monroe, MBA, a heart failure survivor and lead advocate at HeartLife, about her lived experience with spontaneous coronary artery dissection (SCAD) and the systemic failures that nearly cost her life. Following the birth of her third child, Monroe experienced classic cardiac symptoms but was repeatedly misdiagnosed as having indigestion or "hysterical motherhood" despite an EKG confirming an acute myocardial infarction.
30: Debriefing ACC 2026: Key Cardiovascular Trials and Their Clinical Implications for Pharmacists28 Apr 202600:55:40
29: New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities31 Mar 202600:48:00
You can learn more about the 2026 dyslipidemia guidelines here: 2026 Dyslipidemia Guideline Hub | JACC

27: Pharmacists’ Evolving Role in Electrophysiology Takes Center Stage Ahead of ACC 202617 Mar 202600:37:09
You can reach the guests on this episode here:
Kristen Campbell, PharmD
28: Unpacking the 2025 ACC/AHA Pulmonary Embolism Guidelines With a Thrombosis Pharmacist03 Mar 202600:49:50
Learn more about the HI-PEITHO trial here.
You can reach the guest on this episode here:
Allison Burnett, PharmD, PhC, CACP, on LinkedIn
27: Addressing Gaps in Secondary Stroke Prevention With Factor XIa Inhibition17 Feb 202600:10:55
Learn more about the OCEANIC-STROKE trial here.
26: Pharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures10 Feb 202600:07:18
In this Heart Month solo episode of the Tell-Tale Heart podcast, host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP, examines the “hypertension control paradox” outlined in a recent New England Journal of Medicine perspective, exploring why blood pressure control in the United States remains suboptimal despite effective therapies and long-standing clinical guidelines. Beavers reviews national trends showing stalled progress in hypertension control and contrasts them with higher-performing systems that rely on protocol-driven, team-based care models.
© My Podcast Data
About usPrivacy Policy